netFormulary NHS
Coastal West Sussex
Local Health Economy Formulary

Welcome to the Coastal West Sussex Local Health Economy Formulary

Useful Links

Effective Shared Care Agreements (ESCAs) Adult nutrition guidance South Central Antimicrobial Network
Area Prescribing Committee (APC) CWS formulary application forms NICE Technology appraisals adherence checklist
Patient Resources Keeping Tabs Newsletter Infant Feeding Guidelines
Specials Guidance

Policies, Guidelines and Pathways

CWS CCG Website
Continence Formulary Dressings Formulary Blue Coding – Information sheets
Quality Improvement Scheme (QIS) National Reporting and Learning System (NRLS) Sussex Partnership NHS Foundation Trust (SPfT) link
Medicines Supply Updates Medicines Safety Information Sussex Community NHS Foundation Trust (SCfT) link
Individual Funding Requests Self Care Prescribing Guidance
  Download net formulary from Apple IOS Store Google Play net formulary


News Feed

May 2020 - Revised CWS Cannabis Prescribing Position Statement:

A revised position statement on the use of cannabis based products within CWS is now available on the CWS website  - CWS cannabis prescribing position statement 2020

March 2020 - Regular prescribing quantities are NOT to be increased during the Covid-19 crisis:

Clinicians are reminded that prescribed quantities of medication should not be increased during the current Covid-19 crisis.

Patients may well request a larger supply than normal but this should be declined and they should be advised that requesting repeat prescriptions at their usual intervals and for their usual quantities will minimise the chances of the supply chain being disrupted, so all patients can continue to obtain their medication.

March 2020 - Revised CWS Interface Prescribing Policy:

The latest version is now available to access on the Coastal West Sussex Formulary and Coastal West Sussex website.

February 2020 - RMOC Position Statement on Oral Vitamin B Supplementation in Alcoholism:

SPfT are revising their guidance to align with this new Regional Medicines Optimisation Committee (RMOC) guidance, and it was agreed at the CWS Area Prescribing Committee meeting in January, that CWS would adopt this RMOC position statement. It is also available to access on the CWS formulary linked to oral Vitamin B products.

January 2020 - Biomelatonin update:

Pharma Nord have discontinued their supply of “Bio-melatonin®” in the UK, and have brought out a new licensed melatonin in its place. It is only licensed for treatment of jet lag in adults, (the same as the recently released Colonis brand melatonin) and is not recommended for use in patients under 18 years old. This means that we now need to use a licensed product in an “off licence” way.

Further discussions are required to decide the best way forward for prescribing this treatment, but in the meantime, it was agreed that the new Pharma-Nord melatonin should be used in place of Bio-melatonin®.

November 2019 - Managing females of child bearing potential (FCBP) prescribed valproate at the primary/secondary care interface:

  • A primary/secondary care interface document for managing females of child bearing potential (FCBP) prescribed valproate is now available here. It includes a form for patients to complete and sign to acknowledge the potential risks if they are unwilling to engage in the annual review process, but request that their sodium valproate continues to be prescribed.

>>> more news


The Coastal West Sussex local health economy formulary is the output of processes to support the managed introduction, utilisation or withdrawal of healthcare treatments in Coastal West Sussex. It is managed through the Coastal West Sussex Area Prescribing Committee and applies to all prescribers across the local health economy including Coastal West Sussex Clinical Commissioning Group, Western Sussex Hospitals NHS Foundation Trust, Sussex Partnership NHS Foundation Trust and Sussex Community NHS Trust.

The formulary is now up to date with respect to all the traffic light document information as well as the following currently ratified full BNF therapeutic chapters:

-Musculoskeletal and joint diseases
-Low Molecular Weight Heparins
-Ear, nose, and oropharynx

The following sections have been ratified by CWS APC but are only available as standalone documents under the useful links (supporting formulary documents) currently:

-Oral Nutrional Supplements

All NICE positively appraised medicines are automatically included within the formulary (where clinically appropriate) and these can be accessed via the NICE technology appraisal adherence checklist link above. These medicines are available for clinicians to prescribe, should they choose to, in a way that supports safe and clinically appropriate practice. Prescribing responsibility is defined within the traffic light system.

The technology in a NICE technology appraisal may not be the only treatment for a particular condition. If a NICE technology appraisal recommends use of a technology, it is as an option for the treatment of a disease or condition. This means that the technology should be available for a patient who meets the clinical criteria set out in the guidance, subject to the clinical judgement of the treating clinician. The NHS must provide funding and resources when the clinician concludes and the patient agrees that the recommended technology is the most appropriate to use, based on a discussion of all available treatments

The Medicines Management team are always happy to receive any feedback on the formulary. Please use the feedback button at the top of the page if you wish to contact us in relation to the formulary.

Every care has been taken in the compilation and publication of the content on our website. However, Coastal West Sussex Area Prescribing Committee (and its consituent NHS members) will not be held responsible for any loss, damage or inconvenience caused as a result of any inaccuracy or error within these pages.

Please note that all material in this site is aimed at healthcare professionals. Members of the public seeking advice on any medicine-related matters are encouraged to contact NHS 111 or speak with their GP, pharmacist or nurse.

Links are provided for information and convenience only. We cannot accept responsibility for the sites linked to, or the information found there. A link does not imply an endorsement of a site; likewise, not linking to a particular site does not imply lack of endorsement. Links to NHS member organisational policies or guidelines may not be accessible from all locations

We cannot accept any responsibility for any loss, disruption or damage to your data or your computer system that may occur while using material derived from this website.

   Last updated: 22/10/2020 10:23:15.
    Download net formulary from Apple IOS Store  Google Play net formulary